Latest Going Concern Risk News

Multistack International Limited posted a surprising $2.26 million net profit for 2025, driven by one-off settlement income, while its core operations continue to falter, prompting plans to exit its current business model.

Alliance Aviation Services reported a $105.8 million half-year loss driven by significant impairments on its Fokker fleet, even as revenue rose 7.9% on wet lease and aviation services growth. The company is executing a strategic turnaround including fleet renewal and operational realignment.

3D Energi Limited has offered 41.7 million free attaching options to investors from its October 2025 Placement, aiming to clear trading restrictions despite ongoing ASX suspension and financial challenges.

5E Advanced Materials reports Q2 FY2026 results with increased mineral resources and key shipments, while navigating ongoing funding uncertainties.

BCAL Diagnostics reported a slight revenue decline and a persistent net loss in its half-year results, with auditors flagging concerns over its ability to continue without additional funding.

Jayride Group Limited reports a narrower quarterly loss amid revenue challenges, secures $200,000 through convertible notes, and inks a new SaaS agreement with Thailand’s Drivemate to expand its mobility platform.

Resouro Strategic Metals reports a $2.83 million loss for Q3 2025 while progressing its Tiros Titanium Dioxide and Rare Earth Elements Project, highlighted by an updated 1.9 billion tonne mineral resource estimate. The company also secured $3 million in a recent private placement, underpinning its exploration activities.

5E Advanced Materials is raising up to $36 million through a stock offering to fund the development of its Fort Cady boron and lithium project in California. The capital raise comes amid ongoing concerns about the company’s ability to continue as a going concern without further financing.

Anteris Technologies Global Corp. has launched a $230 million equity offering alongside an $84 million private placement with Medtronic’s subsidiary, aiming to accelerate clinical trials and scale manufacturing of its innovative DurAVR Transcatheter Heart Valve.

Sarama Resources Ltd reported a $1.9 million loss for the first nine months of 2025 while securing A$2.7 million in equity funding and advancing a $242 million arbitration claim against Burkina Faso over mining permit expropriation.

Anteris Technologies Global Corp. reported a $22.2 million loss in Q3 2025 while progressing its DurAVR Transcatheter Heart Valve pivotal trial following key regulatory approvals. The company bolstered its cash position with a $25.2 million private placement post-quarter.

McLaren Minerals Limited has announced a fully underwritten non-renounceable pro-rata entitlement offer to raise approximately $3.6 million, issuing new shares at 1.8 cents each with free-attaching options. The capital raise aims to fund exploration and development activities as the company advances its mining projects.